Business Context and Reporting Period
TASER International, Inc. (now associated with AXON Enterprise, Inc.) filed this Form 10-Q for the quarter ended June 30, 2012. The company develops and sells electronic control devices, accessories, on-officer video products, and evidence-management software and services. Reportable segments were ECD and Video, including AXON and EVIDENCE.com.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2012 | Six Months Ended June 30, 2012 |
|---|---|---|
| Net sales | $28.2 million | $53.9 million |
| Gross margin | $16.5 million; 58.5% | $31.7 million; 58.9% |
| Operating income | $6.1 million; 21.5% | $12.5 million; 23.2% |
| Net income | $3.4 million | $7.2 million |
| Diluted earnings per share | $0.06 | $0.12 |
| Operating cash flow | Not separately provided | $13.4 million |
- Second-quarter sales increased 33.1% year over year; first-half sales increased 21.5%.
- Gross margin improved from 57.7% to 58.5% in the quarter and from 55.2% to 58.9% for the first half.
- Cash and cash equivalents were $18.0 million at June 30, 2012; cash, cash equivalents and investments totaled $23.2 million.
- Total assets were $97.8 million and total liabilities were $22.5 million.
- The company had no borrowings under its $10.0 million revolving credit facility and reported no outstanding debt.
- Net cash used in investing activities was $1.0 million, while net cash used in financing activities was $15.7 million, primarily for share repurchases.
Material Changes Versus the Prior Comparable Period
- Revenue growth was primarily driven by TASER X2 adoption, with second-quarter X2 sales of $7.1 million versus $1.4 million in the prior-year quarter. X26 sales declined by $1.4 million as customers moved through the upgrade cycle.
- Video segment sales increased to $1.3 million in the second quarter and $2.2 million for the first half. The company began shipping the AXON Flex camera with EVIDENCE.com software during the quarter.
- Sales, general and administrative expense declined 7.3% in the quarter and 6.2% year to date; research and development expense declined 27.0% and 24.8%, respectively.
- The company recorded a $2.2 million litigation judgment benefit in the first half of 2012, compared with a $3.3 million litigation judgment expense in the first half of 2011.
- No 2012 impairment or property-disposal charges were recorded, compared with $1.4 million of product-line impairment and approximately $0.8 million of property write-downs in the prior-year periods.
- The company repurchased 3.1 million shares for $16.1 million during the quarter under a $20 million authorization. Approximately $3.9 million remained available at June 30, 2012, and an additional 0.5 million shares were repurchased through August 3, 2012.
Guidance, Outlook, Risks and Unusual Items
- Management stated that expected operating cash generation and available cash were sufficient to finance operations and strategic initiatives for 2012 and 2013, while cautioning that future cash flow and borrowing availability were not assured.
- Management estimated a 2012 effective tax rate of approximately 42.2%, before discrete-period adjustments. A $2.0 million liability for unrecognized tax benefits was recorded; recognition could favorably affect the effective tax rate.
- The Turner product-liability case resulted in a $5.5 million judgment plus costs and post-judgment interest. The company maintained a $1.1 million reserve and appealed; estimated uninsured exposure was approximately $1.1 million.
- The company reported 36 product-related lawsuits, including 35 pending cases excluding the Turner matter. Litigation outcomes remain uncertain and insurance may not cover all defense costs or adverse judgments.
- Key operating risks include dependence on X26 and X2 sales, adoption of AXON and EVIDENCE.com, government and customer budget constraints, product-liability litigation, product defects, intellectual-property claims, cybersecurity or service outages, component shortages, foreign exchange, regulatory changes and inventory obsolescence.
- Net deferred tax assets totaled approximately $19.5 million and were subject to management judgments regarding future taxable income and realization.
Important Facts for Investors to Verify
- Verify the company-name transition and historical comparability between TASER International, Inc. and AXON Enterprise, Inc.
- Assess whether X2 upgrade-driven growth and AXON Flex adoption were sustainable beyond the reporting period.
- Review the economics and profitability of the Video segment, which generated negative segment gross margins in the reported periods.
- Monitor cash usage from share repurchases relative to operating cash flow and the remaining liquidity cushion.
- Evaluate potential exposure from the Turner appeal and other product-liability lawsuits, including insurance limits and deductibles.
- Review the realization of deferred tax assets, the $2.0 million uncertain-tax-position liability and the projected 42.2% effective tax rate.